Hip Replacement Surgery

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

BI
Baxter InternationalIL - Deerfield
1 program
1
Fibrin Sealant Vapor-Heated Solvent/Detergent-treatedPhase 31 trial
Active Trials
NCT00161902CompletedEst. Mar 2003

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Baxter InternationalFibrin Sealant Vapor-Heated Solvent/Detergent-treated

Clinical Trials (1)

NCT00161902Baxter InternationalFibrin Sealant Vapor-Heated Solvent/Detergent-treated

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement

Start: Aug 2001Est. completion: Mar 2003
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space